Similar articles

• Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.

  Rose S, Chaudhari A, Peterson CM. Rose S, et al. Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13. Adv Drug Deliv Rev. 2009. PMID: 19445984 Review.
• Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.

  Karri K, Mowbray D, Adams S, Rendal JR. Karri K, et al. Eur J Contracept Reprod Health Care. 2006 Mar;11(1):53-4. doi: 10.1080/13625180500178767. Eur J Contracept Reprod Health Care. 2006. PMID: 16546818
• Levonorgestrel-releasing intrauterine device and uterine perforations.

  [No authors listed] [No authors listed] Prescrire Int. 2007 Dec;16(92):248-9. Prescrire Int. 2007. PMID: 18092420
• Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents.

  Aslam N, Blunt S, Latthe P. Aslam N, et al. J Obstet Gynaecol. 2010;30(5):489-91. doi: 10.3109/01443615.2010.484107. J Obstet Gynaecol. 2010. PMID: 20604653
• The levonorgestrel-releasing intrauterine system in modern gynaecology.

  McGavigan CJ, Owen P. McGavigan CJ, et al. Br J Hosp Med (Lond). 2005 Oct;66(10):574-7. doi: 10.12968/hmed.2005.66.10.19896. Br J Hosp Med (Lond). 2005. PMID: 16255257 Review.